Annual EBITDA:
-$150.57M-$50.04M(-49.77%)Summary
- As of today, VKTX annual EBITDA is -$150.57 million, with the most recent change of -$50.04 million (-49.77%) on December 31, 2024.
- During the last 3 years, VKTX annual EBITDA has fallen by -$95.19 million (-171.86%).
- VKTX annual EBITDA is now -148836.70% below its all-time high of -$101.10 thousand, reached on December 31, 2013.
Performance
VKTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$74.46M-$19.10M(-34.51%)Summary
- As of today, VKTX quarterly EBITDA is -$74.46 million, with the most recent change of -$19.10 million (-34.51%) on June 30, 2025.
- Over the past year, VKTX quarterly EBITDA has dropped by -$40.48 million (-119.14%).
- VKTX quarterly EBITDA is now -2326837.50% below its all-time high of -$3200.00, reached on March 31, 2013.
Performance
VKTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$212.42M-$40.48M(-23.55%)Summary
- As of today, VKTX TTM EBITDA is -$212.42 million, with the most recent change of -$40.48 million (-23.55%) on June 30, 2025.
- Over the past year, VKTX TTM EBITDA has dropped by -$88.04 million (-70.78%).
- VKTX TTM EBITDA is now -193711.13% below its all-time high of -$109.60 thousand, reached on December 31, 2012.
Performance
VKTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VKTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -49.8% | -119.1% | -70.8% |
| 3Y3 Years | -171.9% | -322.3% | -256.6% |
| 5Y5 Years | -364.4% | -685.1% | -445.4% |
VKTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -171.9% | at low | -363.8% | at low | -241.0% | at low |
| 5Y | 5-Year | -364.4% | at low | -661.9% | at low | -445.4% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low | >-9999.0% | at low |
VKTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$74.46M(-34.5%) | -$212.42M(-23.5%) |
| Mar 2025 | - | -$55.36M(-20.0%) | -$171.93M(-14.2%) |
| Dec 2024 | -$150.57M(-49.8%) | -$46.13M(-26.5%) | -$150.57M(-12.7%) |
| Sep 2024 | - | -$36.47M(-7.3%) | -$133.66M(-7.5%) |
| Jun 2024 | - | -$33.98M(+0.1%) | -$124.38M(-9.0%) |
| Mar 2024 | - | -$34.00M(-16.4%) | -$114.07M(-13.5%) |
| Dec 2023 | -$100.53M(-43.5%) | -$29.21M(-7.4%) | -$100.53M(-9.8%) |
| Sep 2023 | - | -$27.19M(-14.9%) | -$91.53M(-13.9%) |
| Jun 2023 | - | -$23.67M(-15.6%) | -$80.40M(-8.1%) |
| Mar 2023 | - | -$20.46M(-1.3%) | -$74.36M(-6.1%) |
| Dec 2022 | -$70.06M(-26.5%) | -$20.21M(-25.9%) | -$70.06M(-12.5%) |
| Sep 2022 | - | -$16.05M(+8.9%) | -$62.29M(-4.6%) |
| Jun 2022 | - | -$17.63M(-9.0%) | -$59.56M(-3.8%) |
| Mar 2022 | - | -$16.17M(-30.0%) | -$57.40M(-3.6%) |
| Dec 2021 | -$55.39M(-30.7%) | -$12.43M(+6.7%) | -$55.39M(-2.3%) |
| Sep 2021 | - | -$13.33M(+13.8%) | -$54.15M(-7.0%) |
| Jun 2021 | - | -$15.47M(-9.3%) | -$50.59M(-13.4%) |
| Mar 2021 | - | -$14.16M(-26.4%) | -$44.61M(-7.9%) |
| Dec 2020 | -$42.38M(-30.7%) | -$11.20M(-14.6%) | -$41.33M(-6.1%) |
| Sep 2020 | - | -$9.77M(-3.0%) | -$38.94M(-6.6%) |
| Jun 2020 | - | -$9.48M(+12.8%) | -$36.54M(+0.1%) |
| Mar 2020 | - | -$10.88M(-23.5%) | -$36.56M(-12.8%) |
| Dec 2019 | -$32.43M | -$8.81M(-19.4%) | -$32.43M(-12.4%) |
| Sep 2019 | - | -$7.37M(+22.4%) | -$28.86M(-2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$9.51M(-41.0%) | -$28.09M(-11.9%) |
| Mar 2019 | - | -$6.74M(-28.7%) | -$25.11M(-15.9%) |
| Dec 2018 | -$26.16M(-37.2%) | -$5.24M(+20.6%) | -$21.66M(-7.0%) |
| Sep 2018 | - | -$6.60M(-1.1%) | -$20.25M(-3.9%) |
| Jun 2018 | - | -$6.53M(-98.2%) | -$19.49M(-9.5%) |
| Mar 2018 | - | -$3.29M(+14.0%) | -$17.80M(+7.8%) |
| Dec 2017 | -$19.07M(-37.7%) | -$3.83M(+34.5%) | -$19.29M(-3.3%) |
| Sep 2017 | - | -$5.84M(-20.9%) | -$18.68M(-15.2%) |
| Jun 2017 | - | -$4.83M(-0.9%) | -$16.21M(-11.5%) |
| Mar 2017 | - | -$4.79M(-49.2%) | -$14.54M(-12.5%) |
| Dec 2016 | -$13.85M(-15.4%) | -$3.21M(+4.9%) | -$12.92M(+11.2%) |
| Sep 2016 | - | -$3.37M(-6.6%) | -$14.55M(+7.1%) |
| Jun 2016 | - | -$3.17M(+0.2%) | -$15.66M(+22.0%) |
| Mar 2016 | - | -$3.17M(+34.4%) | -$20.09M(+10.4%) |
| Dec 2015 | -$12.00M(+48.9%) | -$4.84M(-7.8%) | -$22.42M(-27.5%) |
| Sep 2015 | - | -$4.49M(+40.9%) | -$17.58M(-34.2%) |
| Jun 2015 | - | -$7.59M(-38.0%) | -$13.10M(+53.6%) |
| Mar 2015 | - | -$5.50M(+75.8%) | -$28.22M(-23.0%) |
| Dec 2014 | -$23.47M(>-9900.0%) | - | - |
| Jun 2014 | - | -$22.71M(>-9900.0%) | -$22.93M(-9576.2%) |
| Mar 2014 | - | -$220.00K(-1194.1%) | -$237.00K(-82.6%) |
| Dec 2013 | -$101.10K(+7.8%) | - | - |
| Jun 2013 | - | -$17.00K(-431.3%) | -$129.80K(-15.1%) |
| Mar 2013 | - | -$3200.00(+97.1%) | -$112.80K(-2.9%) |
| Dec 2012 | -$109.60K | -$109.60K | -$109.60K |
FAQ
- What is Viking Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Viking Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Viking Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Viking Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of VKTX is -$150.57M
What is the all-time high annual EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual EBITDA is -$101.10K
What is Viking Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, VKTX annual EBITDA has changed by -$50.04M (-49.77%)
What is Viking Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of VKTX is -$74.46M
What is the all-time high quarterly EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly EBITDA is -$3200.00
What is Viking Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, VKTX quarterly EBITDA has changed by -$40.48M (-119.14%)
What is Viking Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of VKTX is -$212.42M
What is the all-time high TTM EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high TTM EBITDA is -$109.60K
What is Viking Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, VKTX TTM EBITDA has changed by -$88.04M (-70.78%)